![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | August 2022
Sponsoring employers and trustees are expected to understand the implications of refinancing on the employer covenant and to mitigate any detriment as much as possible. The post outlines the key areas parties should consider in relation to restructuring proposals, and highlights that these areas are likely to be challenging in the current inflationary financial climate.
The Regulator reminds trustees to engage with management well ahead of any potential refinancing to ensure they have a strong understanding of the employer's current debt structure. They should also consider debt covenants and refinancing within their monitoring, information sharing and contingency planning frameworks. Employers are expected to provide trustees with "meaningful and timely information". This could include forecasts, scenario analysis and other information provided to the lender which trustees may find helpful as part of their analysis and monitoring.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023